5 eight-stranded jelly-roll motif, also known as the double stranded helix fold or the cupin fold [18, 19] . Two other domains have been identified in the C-P4H subunit, (i) an N terminal dimerization domain (residues 1-143 in the human (I) subunit) important for the dimerization between the two subunits [20] , and (ii) a middle region containing the peptidesubstrate-binding (PSB) domain (residues 144-244 in the human (I) subunit) [21, 22] (Figure   1b ). Protein disulfide isomerase (PDI) [23, 24] serves as the subunit of the C-P4Hs. PDI contains four domains, referred to as a, b, b , and a ( Figure 1b) . Each domain has the typical thioredoxin fold, but only the a and a domains catalyze disulfide bond formation and isomerization via their conserved -Cys-Gly-His-Cys-motifs ( Figure 1b ). The first cysteine is rather solvent exposed, whereas the second cysteine is more buried. In the oxidized state, these two cysteine residues form a disulfide bridge. It appears that the main function of PDI in C-P4H is to facilitate the folding of the chain, as well as to solubilize the otherwise insoluble subunit in a catalytically active, non-aggregated state [25] .
Although C-P4Hs have been studied since the 1960s, structural information on the complete enzyme tetramer is still limited. The crystal structure of human PDI with all four thioredoxin domains was solved recently [26] . Crystal structures of the dimerization and PSB domains of the (I) subunit of human C-P4H-I have also been determined [20, 22] . The structure of the CAT domain of the subunit is not available because of its insolubility, but several crystal structures are currently known from other P4H enzymes having a jelly-roll fold [27] [28] [29] [30] . One of these is the monomeric algal P4H isoenzyme 1 from Chlamydomonas reinhardtii (Cr-P4H-1) [28], a homologue with 26% amino acid sequence identity to the human (I) CAT domain ( Figure 2 ). Cr-P4H-1 has also been crystallized in the presence of a substrate peptide with Ser-Pro repeats [31] . Crystallographic binding studies with the Cr-P4H- 1 [31] and the human C-P4H I) PSB domain [20] have revealed that both of these domains bind a 9-residue proline-rich peptide that is folded into a poly-L-proline type II helix.
Here, we present a detailed bioinformatics analysis of the human C-P4H-I subunit and report a low-resolution small-angle X-ray scattering (SAXS) structure of the complete C-P4H-I heterotetramer in solution. The SAXS analysis shows that the overall shape of C-P4H-I is elongated with bulky lobes at both ends, connected by a thinner waist. The N terminal ends of the dimerized subunits form the central axis of this enzyme while the two PDI/ subunits cover the highly insoluble C terminal CAT domains of its two bulky lobes. Enzyme kinetics provide insight concerning the spatial organization of the binding pockets of the PSB and CAT domains in each of the two lobes.
METHODS

Expression and purification of human C-P4H-I
Human C-P4H-I (Uniprot code P13674-1) was expressed in bacteria (Escherichia coli,
Origami strain) [32], insect cells (Spodoptera frugiperda) [33], and yeast cells (Pichia
pastoris)
[34]. C-P4H-I expression, cell lysis, and protein purification followed the protocols described earlier [32] [33] [34] with slight modifications. The purified proteins are referred to as eC-P4H-I, iC-P4H-I, and yC-P4H-I, respectively, according to the expression host. In the yeast expression system, the PDI/ subunit is preceded by the 85-residue N terminal
Saccharomyces cerevisiae mating factor sequence ( MF) to facilitate protein translocation in the yeast ER [34, 35] . The cells from all three expression systems were lyzed in a buffer containing 10 mM Tris-HCl (pH 7.8), 100 mM NaCl, 100 mM glycine, 10 μM DTT (C-P4H affinity buffer). The soluble fraction of the cell lysates was loaded onto a poly-L-proline (>40000 Da, Sigma) Sepharose matrix immediately after cell lysis. The bound protein was eluted using the C-P4H affinity buffer, supplemented with 3 mg/ml poly-L-proline (1000-10000 Da, Sigma). The fractions containing C-P4H-I were pooled, and the NaCl concentration of the pooled fractions was reduced to 50 mM. The C-P4H-I sample was loaded onto a 5 ml HiTrap Q Sepharose column (GE Healthcare), and the protein was eluted using an 7 increasing NaCl gradient (200 mM to 500 mM, 20 × column volume). The C-P4H-Icontaining fractions were pooled and concentrated using Amicon Ultra centrifugal filters (Millipore) with a molecular weight cutoff of 50 kDa. Size exclusion chromatography (SEC) was carried out in 50 mM Tris-HCl (pH 7.8), 30 mM NaCl, 100 mM glycine, 10 μM DTT, using a 24 ml 10/300 Superdex TM 200 GL column (GE Healthcare) connected to an ÄKTApurifier (GE Healthcare) at a flow rate of 0.25 ml/min. In SEC experiments, the pooled C-P4H-I samples eluted in two or three peaks, the first peak (major peak) being the complete C-P4H-I tetramer (Supplementary Figures S1-S3 ). The purified C-P4H-I samples in SEC buffer were divided into 10-50 μl aliquots and stored at -70ºC after quick freezing in liquid nitrogen.
During and after purification, C-P4H-I samples were analyzed by 8% SDS-PAGE under reducing conditions followed by Coomassie Blue staining. Western blotting was done using a polyclonal antibody generated against the purified recombinant PSB domain of the human C-P4H (I) subunit [36] (Innovagen) and enhanced chemiluminescence detection (Amersham Biosciences). For N terminal sequencing, the protein samples were electroblotted onto a ProBlott membrane (Applied Biosystems Inc.), and protein bands (visualized using Ponceau S) were loaded onto a 492A Protein Sequencer (Applied Biosystems Inc.).
Activity assays and peptides
The catalytic properties of purified C-P4H-I were characterized using a method based on the hydroxylation-coupled decarboxylation of 2-oxo[1-14 C]glutarate [37] . Synthetic peptides with three, five, or ten Pro-Pro-Gly triplets ((PPG) 3 , (PPG) 5 , and (PPG) 10, respectively) were used as substrates, and the liberation of radioactive CO 2 was measured using a Tri-Carb 2900 TR liquid scintillation counter (Perkin Elmer). eC-P4H-I was used for further activity assays with various synthetic peptides, with variations in the number and order of the -PPG-and -PPPtriplets. These hybrid peptides included (PPG) 2 (PPP) 2 P, P(PPP) 2 (PPG) 2 , (PPG) 3 (PPP) 3 , (PPP) 3 (PPG) 3 , (PPG) 4 (PPP) 4 , and (PPP) 4 (PPG) 4 . The inhibitory and/or binding properties of
The solution structure of collagen prolyl 4-hydroxylase 8 poly-L-proline peptides consisting of nine (P9) and 24 (P24) proline residues were also studied. The peptides used in the SAXS measurements were P24 (inhibitor) and (PPG) 8 (substrate). All peptides were from TAG Copenhagen A/S.
Mass spectrometry
Purified C-P4H-I samples were analyzed by electrospray ionization(ESI)-liquid chromatography(LC)-mass spectrometry (MS) on a Q-Tof instrument (Waters Synapt G1), acetonitrile), and incubated overnight at +37°C. The supernatant was subjected to MALDIToF MS using an UltrafleXtreme (Bruker) instrument or acidified with trifluoroacetic acid and analyzed by nano LC-MS on a Synapt G2 (Waters), using standard protocols. Spectra were analyzed and assigned to protein sequences using the software of the instrument supplier (Bruker Biotools and Waters PLGS).
Static light scattering
Absolute molecular weight information for C-P4H-I and its truncated variants was obtained using static light scattering (SLS). The samples were analyzed with the miniDAWN TM TREOS multi-angle light scattering detector (Wyatt Technology), in on-line mode after the sample eluted from the SEC column. Before entering the SLS device, the sample flowed through a RI-101 refractometer (Shodex) for measuring the protein concentration. The molecular weights were calculated using the ASTRA software (Wyatt Technology).
Small-angle X-ray scattering SAXS samples were concentrated to 2-21 mg/ml and stored at -70 C. After thawing, the samples were filtered using 0.22-μm centrifugal filter devices (Millipore), and the protein concentration was re-determined using absorbance at 280 nm. A sample of the identical buffer was always used as a blank measurement.
SAXS data for eC-P4H-I were also collected in the presence of 100 and 300 μM of the peptides (PPG) 8 and P24. All peptide measurements (including one apo eC-P4H-I control without peptide) were done in the presence of the C-P4H inhibitors 50 M Zn 2+ and 60 M pyridine 2,4-dicarboxylate (PDC, a 2OG analogue). Zinc and PDC were added to the sample by dialyzing the concentrated protein-peptide samples in the C-P4H SEC buffer supplemented with 50 μM ZnSO 4 and 60 M PDC.
Initial SAXS data of the eC-P4H-I and its truncated variant were collected using synchrotron radiation at MAX-Lab (Lund, Sweden) and ESRF (Grenoble, France). All the final SAXS data were collected on the EMBL/DESY (Hamburg, Germany) beamline P12
(PETRA III) [38] . SAXS data processing, analysis, and molecular modeling were carried out using ATSAS [39] . As control samples, well-behaving monomeric proteins, such as bovine serum albumin, calmodulin, and myelin protein P2 [40] were always included in the assay series, to enable reliable molecular weight determination. Molecular masses of the samples were estimated by comparing the observed forward scattering, I(0), to that obtained using standard proteins. Data processing was done using PRIMUS [41] , distance distribution functions were calculated using GNOM [42] , and ab initio chain-like models were built using GASBOR [43] . Rigid body refinement, using models derived from crystal structures, coupled to building of missing loops of the C-P4H-I tetramer was done using CORAL [44] and BUNCH [45] and the scattering data of eC-P4H-I. Model building was based on the crystal structure of human PDI (residues 18-476, PDB entry 4ELI) [26] , the crystal structure of the N terminal region of human C-P4H-I (I) (residues 3-238, PDB entry 4BT9) [20] , and a model of the human C-P4H-I (I) CAT domain (residues 309-504, see the details below).
Theoretical scattering curves were calculated using CRYSOL [46] .
Bioinformatics methods
The atomic model coordinates for the C-P4H-I (I) CAT domain were generated with MODELLER [47] by using the crystal structure of (Ser-Pro) 5 [49] were used for various sequence analyses including secondary structure predictions for the complete subunit of C-P4H-I.
RESULTS
Bioinformatics studies of the C-P4H subunit isoforms
The amino acid sequences of various C-P4H subunits were studied using several bioinformatics tools. All known C-P4H subunits contain three domains (Figure 1b) , the C terminal CAT domain being the most conserved ( Figure 2 ). Unlike for the N terminal region, consisting of the dimerization and PSB domains (also referred to as the double domain, DD)
[20], a crystal structure of the C terminal CAT domain has not yet been determined, due to its poor solubility. However, according to secondary structure predictions and 26% sequence identity, the structure of the CAT domain is proposed to be very similar to that of Cr-P4H-1 participate in peptide substrate binding by the C-P4H CAT domain. All these residues are fully conserved in the C-P4H family ( Figure 2 ). The major differences between algal/plant P4Hs and C-P4Hs are the absence of an extended loop (15 residues) between IV and V in C-P4H and the extra C terminal extension (10 residues) present in the C-P4H family but not in Cr-P4H-1 ( Figure 2 ). The extra C terminal residues of the C-P4H subunit are predicted to be ordered but possibly without secondary structure. It can also be noted that this extension and its immediate neighboring sequence have a number of fully conserved residues, such as Glu506, Phe507, Arg509, Pro510, and Cys511 ( Figure 2 ). Cys511 is important for the assembly of the C-P4H tetramer and may form an intrachain disulfide bridge with Cys486 ( VII) [15] . Interestingly, the corresponding cysteine of Cr-P4H-1 (Cys230) forms a disulfide bridge with Cys195 of its extended IV-V loop [28] .
The region between the PSB and CAT domains has unknown structure and function.
This 70-residue segment, from Lys239 to Pro308, is referred to as the linker region ( Figure 2 ).
Our bioinformatics analysis proposes that the C terminal end of the linker region (Arg287-Pro308) forms part of the CAT domain, having two additional strands ( 1 and 2) when compared to the crystal structure of Cr-P4H-1. The N terminal part of the linker (Lys239-Arg286) is predicted to be solvent-exposed, with one helix ( 12) . The linker region contains several fully conserved residues, including Arg269, Tyr272, Glu273, Leu275, and Cys276 in the 12 helix, and Leu291, Cys293, and Tyr295 in the 1 strand. Cys276 and Cys293 are important for the assembly of the C-P4H-tetramer, possibly by forming an intrachain disulfide bond in the subunit [50] .
Purification and initial characterization of the complete human C-P4H-I tetramer and its truncated variants expressed in E. coli
eC-P4H-I was purified using poly-L-proline affinity, anion exchange chromatography, and SEC. The major peak of the SEC chromatogram of the eC-P4H-I sample (Supplementary Figure S1 ) corresponds to a molecular mass of 250 kDa in the SLS analysis (Table 1) , and
Western blot and MS analyses revealed that both and subunits are present in the single Figure S1 ). Further MS analysis showed that the full masses of the (including the additional N terminal Met residue) and PDI/ subunits were 59241 Da and 55423 Da, respectively. These data indicate that the major peak of SEC represents the eC-P4H-I heterotetramer. Activity analysis of this sample showed that this tetramer is fully active when compared to earlier data [32-34].
SDS-PAGE band of 60 kDa (Supplementary
The expression and purification of eC-P4H-I also generated a truncated variant, which co-eluted with the complete eC-P4H-I tetramer during poly-L-proline affinity chromatography, but which was separated from the tetramer during SEC (Supplementary Figure S1 ). According to SLS, the molecular mass of this eC-P4H-I minor peak was 148 kDa (Table 1) From now on, the truncated eC-P4H-I variant (the eC-P4H-I minor peak of the SEC step) is referred to as eC-P4H-I( ´´) and the complete eC-P4H-I tetramer is referred to as eC-P4H-I( In activity assays, eC-P4H-I( ´´) has similar specific activity as eC-P4H-I( .
truncated variants expressed in yeast and insect cells
Recombinant human C-P4H-I tetramers expressed in insect cells (referred to as iC-P4H-I) and in the yeast P. pastoris (referred to as yC-P4H-I) are modified by glycosylation [33, 34] . To investigate whether glycosylation affects the C-P4H-I tetramer structure, C-P4H-I expressed in these eukaryotic systems was also studied. yC-P4H-I and iC-P4H-I were purified using the same protocol as eC-P4H-I. Like for the eC-P4H-I purification, in the final SEC step, two peaks were observed (Table 1 Figure 2 ). These data propose that the minor peaks of yC-P4H-I and iC-P4H-I correspond to a dimeric C-P4H-I, having a full-length subunit and a truncated subunit (~45 kDa) starting at Asp122. These truncated variants of yCP4H-I and iC-P4H-I are referred to as yC-P4H-I( ´) and iC-P4H-I( ´), respectively. Unlike eC-P4H-I( ´´), yC-P4H-I( ´) and iC-P4H-I( ´) are completely inactive.
Solution structure of the complete C-P4H-I tetramer and its truncated variants
Synchrotron SAXS data were collected for the complete eC-P4H-I and yC-P4H-I tetramers and their truncated variants (Figure 3a ,b; Table 2 ). The complete human C-P4H-I tetramer, regardless of the expression host, is an elongated, somewhat curved complex (Figure 3c,d ).
The distance distribution functions of the eC-P4H-I( ) and yC-P4H-I( ) tetramers are slightly different (Figure 3b ). The maximal dimensions are 275 Å for the yC-P4H-I and 290 Å for eC-P4H-I, with R g values slightly above 80 Å ( Table 2 ). The ab initio models of eC-P4H-I( ) and yC-P4H-I( ) show that the enzyme has two-fold symmetry, with a thin middle part (waist) and bulkier lobes at both ends (Figure 3c,d) . The eC-P4H-I( ´´)
and yC-P4H-I( ´) variants have a lower mass, R g , and D max than the complete heterotetramer (Table 2) , and their shape is also asymmetric (Figure 3e ,f).
To study the effect of proline-rich peptides on the C-P4H shape, eC-P4H-I( ) was studied by SAXS in the presence of a peptide substrate (PPG) 8 and an inhibitor P24 ( Figure   4 ). Both peptides change slightly the shape of the C-P4H-I tetramer (Table 2 ; Figure 4a ,b). C-P4H-I complexed with a proline-rich peptide ligand is more compact, having smaller R g and D max values compared to apo C-P4H-I (Table 2) . This difference is also seen in the dimensionless Kratky plot (Figure 4c ), suggesting that upon peptide binding C-P4H-I becomes more compact and more rigid.
Hybrid modeling of C-P4H-I
The SAXS ab initio envelopes of eC-P4H-I and yC-P4H-I (Figure 3c,d) To obtain a better insight into the C-P4H-I solution structure, hybrid modeling approaches using CORAL [44] and BUNCH [45] were employed, involving the use of rigid body models of the separate domains, supplemented by building of loops and termini as chain-like structures. First, a SAXS hybrid model was calculated for the yC-P4H-I( ´), for which high-quality SAXS data were measured (Table 2 ; Figure 3a ,b,f). As the ´ chain of this truncated variant lacks the dimerization domain, only the Asp122-Glu238 region of the C-P4H-I DD crystal structure (including 6 of the dimerization domain and the whole PSB domain) [20] was included. Modeling using three rigid bodies (PSB, CAT, and PDI) suggests that the PDI and CAT domains form a tight ´ complex (Figure 5a ). In the model, no interactions are seen between the PDI and PSB domains, whereas the PSB and CAT domains are in close contact (Figure 5a ). The 70-residue linker region between the PSB and CAT domains, connects the PSB and CAT domains adopting a compact random coil structure. The C terminal residues of the PDI/ subunit (32 residues including the KDEL ER retention signal) as well as the N terminal 74 residues of the MF sequence of the PDI/ subunit (excluding the ER targeting signal of MF [34]) are solvent-exposed (Figure 5a ). This hybrid model fits well to the experimental scattering data collected from yC-P4H-I( ´) (Figure 5e ).
Subsequent modeling of the complete C-P4H-I tetramer was based on the assumption that the CAT-PDI/ assembly is the same in the complete tetramer as in yC-P4H-I( ´), but that the PSB domain may adopt another position in the complete tetramer. Therefore, only the CAT-PDI/ part of the yC-P4H-I( ´) hybrid model (excluding also the linker region of the chain as well as the MF sequence of the chain) was subsequently used for hybrid modeling of the complete eC-P4H-I( ) tetramer. The SAXS ab initio model of the DD construct has the same shape as its various crystal structures [20] , suggesting that the conformation of the DD region is well defined and will be preserved in the complete tetramer. Consequently, the SAXS hybrid model calculations were done using two rigid units, being the DD structure as well as the two CAT-PDI/ assemblies, and using P2 symmetry. The resulting hybrid model of eC-P4H-I( ) fits well to the experimental SAXS data (Figure 5f ) as well as to the corresponding ab initio shape (Figure 5b ). In the model, the DD dimer defines the P2 Taken together, the SAXS experiments show that: i) the C-P4H-I tetramer is an elongated molecule with two-fold symmetry, with the CAT domains pointing away from each other, ii) the central part of the tetramer is a thin region which accommodates the dimerization region of the subunits, iii) there is close interaction between the CAT domain and the PDI/ subunit, and iv) the bound substrate and inhibitor peptides induce a conformational change in the C-P4H-I( ) tetramer, making it more compact.
Kinetic analysis of C-P4H-I with proline-rich peptides
To study the C-P4H-I reaction mechanism, kinetic assays were performed with eC-P4H-I( ) using various proline-rich peptides ( 4 . Thus, the hybrid peptide having the PPG repeat at the N terminal end has a higher affinity for eC-P4H-I( ) than the peptide with the same length but having the PPG repeat at the C terminal end. Typically, longer peptides are better substrates for C-P4Hs [4] . This is also seen in our activity measurements (Table 3) . For the shortest hybrid peptides, (PPG) 2 (PPP) 2 P and P(PPP) 2 (PPG) 2 , the latter peptide is not a substrate, but instead acts as an inhibitor when (PPG) 10 is used as a substrate, whereas (PPG) 2 (PPP) 2 P is a weak substrate with K m close to 1 mM (Table 3) .
C-P4H-I is effectively inhibited by long poly-L-proline peptides [4] . However, the inhibition of C-P4H-I by short poly-L-prolines has not been studied in detail before. We showed before that P9 has high affinity (10 μM) towards the PSB domain of C-P4H-I [20] .
Therefore, this peptide was also included in the enzyme kinetic assays, the assumption being that it binds to the PSB domain and thereby affects the activity of the C-P4H-I tetramer.
However, C-P4H-I was only inhibited (30% inhibition) at a very high concentration (4 mM) of P9, when (PPG) 10 was the substrate. In the presence of 2 mM P9, C-P4H-I was inhibited by 3-14%, when (PPG) 10 was used, but no inhibition was observed when a shorter peptide, (PPG) 3 , was used as a substrate.
DISCUSSION
The assembly
The crystal structure of the DD region of the C-P4H (I) subunit has important implications for understanding the C-P4H assembly, showing that the N terminal helices of the subunit are responsible for the -dimerization [20] . This finding provided also a reliable starting point for the SAXS modeling of the C-P4H-I tetramer structure ( Figures 5 and 6 ). The two dimerization domains, as seen in the DD crystal structure, are at the center of the model of the tetramer, being extended at both ends by the PSB domain. The PDI/ subunit and the CAT domain of the subunit are located at the ends of the bilobal complex. According to the model of yC-P4H-I( ´), the PDI/ subunit closely interacts with the CAT domain. The PDI/ subunit is essential for keeping the C-P4H subunit soluble [25] , and indeed, the CAT domain is the only domain of the subunit, which cannot be recombinantly expressed as an individual domain because of its poor solubility. The role of PDI/ in the assembly process of C-P4H is not clearly established [6] . Most likely, it is involved in chaperoning the folding and SS-bridge formation (oxidation) of the subunit. If in the so-formed C-P4H complex, the subunits remain associated after assembly, then PDI/ will be in the reduced form (active sites in the SH form) and the subunit will be in the oxidized (SS bridged) form.
However, it has been reported that in the active C-P4H tetramer, both the and PDI/ subunits are oxidized [51] . It is possible that the reduced PDI is exchanged for its oxidized form, or that the CAT domain is oxidized in some other way (for example by glutathione
[50]) before forming a complex with oxidized PDI. Much structural information has been obtained recently for the PDI/ subunit due to the crystal structure determination of fulllength PDI in its reduced and oxidized (having active sites SS bridged) forms [26, 52, 53 ]. In the latter form, the b and a domains form an extensive hydrophobic surface, believed to play an important role in the chaperone activity of PDI [26, 54] . In our SAXS model calculated using the oxidized PDI structure, the CAT domain interacts with both PDI/ active site regions being bound in the cleft shaped by the a and a' domains of PDI ( Figures 5 and 6 ), similarly to the ERp57-tapasin complex [55] . The CAT domain interacts with the a, b , and a domains of PDI/ , whereas no interactions are seen with the b domain. This is in line with mutagenesis experiments that show that a, b and a domains are needed for the formation of the active C-P4H-I tetramer [56] . Interestingly, the active site of the a domain (Cys36 and Cys39) is close to Cys486 of the subunit, which may form an intrachain disulfide bridge with Cys511 in the C-P4H-I tetramer ( Figure 6 ). Although it has been shown that PDI activity is not needed for C-P4H-I tetramer formation or activity [25] , the close location of the PDI active site to the possible disulfide bridge of the subunit suggests that the active site of PDI could play a role in the formation and stabilization of disulfide bridges in the C-P4H I)
subunit. In Cr-P4H-1, the long IV-V loop covers the cysteine residue corresponding to the C-P4H-I (I) Cys486 [28] . A similarly elongated IV-V structure is not found in the subunit of any tetrameric C-P4H (Figure 2) , correlating with the notion that the IV-V loop is topologically replaced by PDI/ in the C-P4Hs. Indeed, our model suggests that the a domain of PDI/ interacts with this part of the subunit in the tetramer. The KDEL region at the C terminus of the a domain of PDI is solvent-exposed, in agreement with its role as an ER retention signal ( Figure 6 ).
Human C-P4H-I has two N-linked glycosylation sites (Asn96 and Asn242), but the glycosylation is not required for the assembly or activity of the C-P4H-I tetramer [15] . The glycosylation of iC-P4H-I( ) and yC-P4H-I( ) has not been characterized in detail, but it has been shown with C-P4H-I purified from chicken embryos that when both sites are maximally glycosylated, both sites are occupied by N-linked eight-mannose oligosaccharide units [57] . In yC-P4H-I the level of glycosylation is likely to be somewhat higher than in the native C-P4H-I, as hyperglycosylation of recombinant proteins expressed in yeast is known 
The truncated ´ and ´´ variants
Human C-P4H-I purified from eukaryotic (yeast and insect) and prokaryotic (E. coli) expression systems consists of a mixture of complete tetramers and differently truncated variants. The complete tetramer and its truncated forms co-purified when using the poly-Lproline affinity column, which indicates that each of these variants has at least one functional PSB domain. The truncated iC-P4H-I and yC-P4H-I variants are ´ dimers, built up of a complete PDI/ subunit complexed with an N terminally truncated chain ( ´). The truncated eC-P4H-I, a ´´ trimer, instead, is built up of a complete unit, which is further dimerized with a truncated subunit ( ´´) lacking the CAT domain. The ´ assembly is inactive, whereas the ´´ is active. Apparently, dimerization between the subunits has an important role in achieving a competent PSB-CAT assembly in the first subunit. Indeed, the N terminal dimerization domain of the second subunit interacts with the PSB domain of the first subunit as seen in the DD crystal structure [20] . Helix 5 also plays an important role in the PSB-dimerization domain assembly [20] . This helix, with a high sequence conservation within the C-P4H family (Figure 2) , is not present in the inactive ´ assembly. In addition to residues that form contacts between the dimerization and PSB domains, the 5 helix contains several other highly conserved residues such as Glu108, Asp109, Arg119, Asp122, and Tyr124 (Figure 2 ), which are fully solvent-exposed in the DD crystal structure [20] . Although these conserved residues are not important for the folding or stability of the DD region, the high sequence conservation suggests that they are important for the folding and/or function of the C-P4H tetramer. The PSB domain of the ´´ subunit is probably not functional, because it lacks 11, which has several conserved residues important for peptide-substrate binding, such as Tyr230 and Tyr233 (Figure 2 ) [20, 22] .
The processivity and topology of the C-P4H-I peptide substrate interactions
The substrate of C-P4H is a monomeric procollagen polypeptide, which in the case of the fibril-forming type I, II, and III collagens contains multiple X-P-G tripeptide motifs amounting to approximately 1000 residues. C-P4H is a very efficient enzyme when acting on its procollagen substrate. The k cat /K m ratio is much higher than the rate for diffusioncontrolled encounter between an enzyme and its substrate, suggesting that C-P4H is a processive enzyme when hydroxylating procollagen [58] . Processive enzymes remain bound to their substrates, while performing multiple rounds of catalysis. Well-studied processive enzymes use electrostatic (e.g. DNA processing enzymes) or hydrophobic interactions (e.g.
cellulases) for retaining their substrates [59, 60] . Characteristically, these enzymes have relatively large binding surfaces between ligand and enzyme. The PSB and CAT domains of C-P4H contain many conserved solvent-exposed aromatic residues in their peptide binding sites (Figure 2 ), which can form stacking/C-H... interactions with multiple proline residues of collagenous peptides [20, 31] . Early studies on the hydroxylation of a (PPG) 10 peptide have shown that hydroxylation is most prominent at the C terminal end of the peptide [61] . This observation is consistent with the notion that the catalytic machinery of C-P4H is processive, for example that it is effectively moving from the N to the C terminus of the procollagen substrate. The PSB domain has low affinity for the hydroxylated peptide product generated by the CAT domain [62] . This observation suggests that the hydroxylated peptide triplet in the CAT domain has to move away from the PSB domain, which implies that the CAT-PSB unit moves towards the C terminus of the monomeric procollagen chain ( Figure 6 ). The PSB binding pocket interacts with its ligand in such a way that the C terminal helix ( 11) interacts with the N terminus of the peptide [20] . All these observations predict that the PSB domain binds downstream, at the C terminal end of the procollagen peptide substrate with respect to the CAT domain ( Figure 6 ). Experiments with hybrid peptides with mixed PPG and PPP regions indeed showed that peptides with the PPG region at the N terminus and the poly-Lproline part at the C terminus are higher affinity substrates for C-P4H-I than the peptides with a reverse order (Table 3) . Peptides with an N terminal PPG part are apparently better positioned for catalytically competent interactions with the CAT active site, whenever the C terminal PPP part binds to the PSB domain (it should be noted that poly-L-proline peptides have higher affinity to PSB domain than (PPG) n peptides [20, 62] ). Hybrid peptides with different lengths were tested to get some insight into the spatial separation of the peptidebinding pockets in the PSB and CAT domains. The longest hybrid peptide tested, having an N terminal PPG region, was the best substrate for C-P4H-I, indicating that the peptide is long enough for the PPG region to reach the CAT active site. Also (PPG) 3 (PPP) 3 was a good substrate. However, the shortest hybrid peptide of our study with an N terminal PPG region, (PPG) 2 (PPP) 2 P, is only a weak substrate for C-P4H-I. Apparently, this peptide binds mainly to the PSB domain, and in this mode of binding, the PPG region is not optimally placed for competent interactions with the active site of the CAT domain.
The longest hybrid peptides with an N terminal PPP region, the ((PPP) 4 (PPG) 4 and (PPP) 3 (PPG) 3 ), are substrates for C-P4H-I, but the K m values are significantly higher than for the peptides of reversed order. Our data predict that the PPG regions of these peptides are hydroxylated by the CAT domain being bound in such a way that the PPP region cannot interact with the PSB domain ( Table 3 ). The short peptides P(PPP) 2 (PPG) 2 and P9 are weak inhibitors of C-P4H-I when tested with (PPG) 10 as substrate. We assume that they both bind to the PSB domain only, leaving the CAT domain free for catalysis.
The possible function of the PSB domain
The peptide binding studies raise an interesting question about the functional interaction of the PSB and CAT domains. Our enzymatic assays in the presence of P9 (which has high affinity for the PSB domain [20] ) propose that C-P4H-I can hydroxylate synthetic (PPG) n peptides in vitro without the substrate peptide binding to the PSB domain (Table 3 ). This is also in line with results obtained from complementary point mutation studies of the PSB domain and the complete C-P4H-I [22] . The in vivo function of the PSB domain may relate to capturing the long procollagen chain. It is noteworthy that procollagen chains have variable X-Y-G sequence repeats [1] , and the PSB domain might be important in binding to specific regions (with very high affinity), in order to facilitate the hydroxylation of several PPG motifs up-stream, before the procollagen chain is released from the PSB domain. Concerning the reaction mechanism, it is interesting to note that the CAT domain binds the cosubstrate, 2OG, in a completely buried fashion, in a pocket shielded from bulk solvent by the bound prolinerich peptide [28, 31] . During each reaction cycle, 2OG is converted into succinate (Figure 1 ).
Therefore, completion of the reaction cycle requires that the product peptide must dissociate from its binding site, allowing succinate to be exchanged for a new 2OG molecule. This suggests a function for the PSB domain in holding on to the procollagen substrate, while a competent active site of the CAT domain is regenerated. The affinity of the PSB domain for its bound peptide determines its relative "residence" time, during which the catalytic domain can hydroxylate several PPG tripeptide repeats [58] . This hypothesis suggests that the number of residues between the catalytic site interactions (labelled as C1 to C9 in Table 3 ) and the anchoring interactions (labelled as P1 to P9 in Table 3 ) can vary (referred to as "X" in Table   3 ). According to the SAXS model, the PSB and CAT domains closely interact. The smallest number of X residues is zero, meaning that a 9-residue peptide bound to the PSB binding pocket is 5-13 residues towards the C terminus from the hydroxylation site (Table 3) . Indeed, our SAXS peptide binding studies showed that in the presence of the P24 and (PPG) 8 peptides, the C-P4H-I tetramer adopts a more compact shape ( Table 2 ), suggesting that a peptide can bind to both the CAT and PSB domains simultaneously.
CONCLUSIONS
The proposed quaternary structure of C-P4H-I provides a functional model for the organization of all subunits and domains in the complete C-P4H tetramer assembly ( Figure 6 ).
The unique function of each domain of the subunit can now be proposed: the N terminal coiled-coil motif of the subunit provides the stability of the 2 dimer, and the PSB domain anchors the procollagen substrate, such that several catalytic cycles by the CAT domain are possible before the release of the procollagen substrate. The CAT domain forms the major site of interaction between the chain and the PDI/ chain. The finding that the C-P4H-I tetramer is an elongated symmetric molecule with a architecture also defines the topology of the competent enzyme-substrate complex, such that effectively the CAT-PSB unit moves over the procollagen polypeptide from the N towards the C terminus ( Figure 6 ). The model also suggests that the two CAT-PSB units of the tetramer are located far apart and function independently, which is in good agreement with the observation that the eC-P4H-I( ´´)
variant is fully active. Interestingly, however, inactivation of one of the catalytic sites in the Caenorhabtidis elegans C-P4H tetramer with dissimilar subunits reduced the total activity by more than half, indicating some co-operativity [63] . The observation that the ´ variant of human C-P4H-I is inactive highlights the importance of the -dimerization interactions for the proper assembly and functioning of this C-P4H. We have initiated further structural studies in order to establish the structural details of the C-P4H tetramer assembly at high resolution, as well as to elucidate the precise interactions of the PSB and CAT domains with the procollagen substrate. 
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Figure 6
Schematic model for the domain assembly of the C-P4H-I heterotetramer. The predicted mode of binding of a partially hydroxylated procollagen peptide is also shown. This topology is such that the unhydroxylated peptide forms an initial enzyme-substrate complex with the PSB domain. The region at its N terminal end extends to the catalytic site (black asterisk) and becomes hydroxylated. "X" refers to the variable region of the procollagen chain, as defined in Table 3 . The model visualizes also the proposed disulfide bonds Cys276-Cys293 and Cys486-Cys511 in the subunit [15, 50] . The active sites of the PDI/ subunits are indicated by red asterisks. The location of the known glycosylation sites of the subunits are marked as gray polygons. The label CC identifies the N terminal coiled-coil dimerization domain. 
